Charles River Unveils Apollo™ for CRADL®: Accelerating Drug Discovery

Charles River Laboratories International, Inc. has introduced Apollo™ for CRADL®, a secure, cloud-based platform that revolutionizes vivarium rental services by streamlining research processes. Designed to support clients launching or expanding drug discovery programs, Apollo simplifies onboarding and integrates seamlessly with Charles River’s Research Models Online Ordering System, training tools, and other services. This centralized platform provides direct control over reservations, protocol management, and research execution, enabling faster and more efficient project initiation.

Mark Mintz, Corporate Senior Vice President and CIO of Charles River, emphasized Apollo's role in driving the company's digital transformation, offering clients access to real-time data and tools that optimize research processes. With applications extending across safety assessment, biologics, oncology studies, and more, Apollo represents a comprehensive innovation aimed at accelerating drug discovery and development. By reducing administrative hurdles and enhancing operational efficiency, Charles River continues to lead in delivering cutting-edge solutions for the scientific community.